CNPR Cheat Sheet 2026

The 30 highest-yield CNPR facts, distilled from real exam questions. Print it, save it as a PDF, or study it here — free, no sign-up.

1. Under the FDA's regulations, what is the primary purpose of a Risk Evaluation and Mitigation Strategy (REMS)? → To ensure the benefits of a drug outweigh its serious risks
2. What is the PRIMARY purpose of obtaining CNPR certification in Certified National Pharmaceutical Representative? → To demonstrate verified competency and adherence to professional standards
3. Which of the following medications is classified as an antihypertensive? → Lisinopril
4. Why is active listening important in sales? → To gather information and respond meaningfully
5. Step therapy requires patients to: → Try a less expensive or preferred drug before coverage is granted for a higher-tier drug
6. What is the PRIMARY purpose of obtaining CNPR certification in Certified National Pharmaceutical Representative? → To demonstrate verified competency and adherence to professional standards
7. Which phase focuses on long-term safety and effectiveness after approval? → Phase IV
8. Which regulatory concept requires that drug manufacturers demonstrate their manufacturing processes consistently produce a product meeting its specifications? → Process Validation
9. What is the benefit of continuous integration in CNPR workflows? → It detects integration issues early through frequent builds and tests
10. Under FDA regulations governing pharmaceutical promotion, what does the term 'fair balance' require? → Risk information presented with similar prominence and depth as benefit information
11. How should pharmaceutical reps handle objections? → Acknowledge and address objections with data
12. A physician consistently prescribes a competitor's drug despite similar efficacy to yours. What is the most appropriate first step? → Identify the physician's specific clinical concerns and address them with data
13. What is the significance of a p-value less than 0.05 in clinical trial results? → There is a statistically significant difference unlikely due to chance alone
14. In CNPR practice, what is the best approach to quality improvement in market analysis? → Use data-driven methods with measurable outcomes
15. When a pharmaceutical company files a citizen petition to delay a generic drug's approval, the FDA must respond within: → 150 days
16. What is a 'generic equivalent' drug required to demonstrate to receive FDA approval? → Bioequivalence to the reference listed drug (RLD), meaning similar bioavailability
17. Which personal protective equipment (PPE) principle applies to ALL CNPR certified professionals regardless of their specific role? → PPE must be properly fitted, maintained, and replaced as needed
18. The requirement for pharmaceutical companies to submit 'Dear Healthcare Provider' (DHCP) letters is typically triggered by: → Important new safety information such as a label change or market withdrawal
19. Which practice improves the security of drug development process implementations? → Input validation and principle of least privilege
20. What is the recommended first step when a CNPR professional identifies a compliance violation? → Document and report through proper channels
21. Which FDA designation is granted to drugs targeting serious conditions where the drug demonstrates substantial improvement over available therapies? → Breakthrough Therapy Designation
22. What is the most important professional competency for CNPR certification in market analysis? → Deep knowledge combined with practical application skills
23. What is the first priority in clinical trials for CNPR practitioners? → Ensuring patient safety and well-being
24. In CNPR certification, what is the purpose of automated testing? → To catch regressions and verify functionality continuously
25. How does the CNPR body of knowledge relate to daily professional practice? → It provides the foundational framework that guides decision-making and standard practices
26. Which of the following activities by a pharmaceutical sales representative would be considered a violation of FDA promotional regulations? → Claiming a drug is effective for a use not listed in its approved labeling
27. Which foundational principle is MOST important for success in the Certified National Pharmaceutical Representative profession? → Commitment to continuous learning, ethical practice, and quality outcomes
28. In CNPR practice, what is the best approach to quality improvement in product knowledge? → Use data-driven methods with measurable outcomes
29. Who oversees the drug approval process in the EU? → EMA
30. Which approach best demonstrates mastery of physician relations in CNPR practice? → Applying principles to novel situations with sound judgment